Modulight Biotherapeutics

BiotechnologySeedBoston, USmodulight.bio

Latest round

Seed

Last raised

Nov 2025

Total raised

$12M

Investors

8

About Modulight Biotherapeutics

Based in Massachusetts, US, and founded in 2022, Modulight Biotherapeutics operates as a biotechnology company that offers precision treatments for various disorders.fund, Saras Capital, SilverArc Capital, and Sha’ar Mivnim. The company develops precision treatments for various neurological disorders characterized by pathological activity in the brain. The company leverages a new generation of inhibitory G protein-coupled receptor (GPCR) opsins to develop a platform that can reduce communication between neurons on demand when activated with light. The platform treats a range of neurological disorders, including epilepsy, Parkinson’s disease, and neuropathic pain.

Who invested in Modulight Biotherapeutics

8 investors across 1 round

See all investors in Modulight Biotherapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Nov 12, 2025

    Amount

    $12M

    Investors

    Locked

Questions about Modulight Biotherapeutics

Who invested in Modulight Biotherapeutics?

Modulight Biotherapeutics has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Modulight Biotherapeutics raised?

Modulight Biotherapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Modulight Biotherapeutics last raise money?

Modulight Biotherapeutics's most recent round on record is a Seed, in Nov 2025.

What does Modulight Biotherapeutics do?

Based in Massachusetts, US, and founded in 2022, Modulight Biotherapeutics operates as a biotechnology company that offers precision treatments for various disorders.

Where is Modulight Biotherapeutics headquartered?

Modulight Biotherapeutics is headquartered in Boston, US.

Which VCs invest in companies like Modulight Biotherapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Modulight Biotherapeutics's stage. Their profiles are linked below.

Raising like Modulight Biotherapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.